Abstract 15424: Clinical Implications of Dual Antiplatelet Therapy Cessation Within 12 Months of Coronary Stenting in Men and Women: A Pooled Analysis From the Platinum Diversity and Promus Element Plus Post-Approval Studies

Rishi Chandiramani,Davide Cao,Roxana Mehran,Moritz Blum,Anastasios Roumeliotis,Ridhima Goel,Samantha Sartori,Scott Davis,Luis Tami,John Wang,Islam Othman,Osvaldo Gigliotti,Kevin Boran,Henry A. Liberman,Paul Underwood,Dominic J. Allocco,Wayne Batchelor

Abstract 15424: Clinical Implications of Dual Antiplatelet Therapy Cessation Within 12 Months of Coronary Stenting in Men and Women: A Pooled Analysis From the Platinum Diversity and Promus Element Plus Post-Approval Studies

2019

Rishi Chandiramani
Davide Cao
Roxana Mehran
Moritz Blum
Anastasios Roumeliotis
Ridhima Goel
Samantha Sartori
Scott Davis
Luis Tami
John Wang
Islam Othman
Osvaldo Gigliotti
Kevin Boran
Henry A. Liberman
Paul Underwood
Dominic J. Allocco
Wayne Batchelor

Introduction: Cessation of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) may increase the risk of recurrent ischemic events. While the incidence and patterns of st...

Keywords:

coronary stenting
Conventional PCI
Medicine
Internal medicine
pooled analysis
Percutaneous coronary intervention

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations